AI assistant
Sending…
Chemomab Therapeutics Ltd. — Director's Dealing 2021
Mar 25, 2021
35107_dirs_2021-03-25_4c6a6989-896c-4db5-aee7-f79c9e70cb85.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16
Reporting Person: Maryles Joel Michael (Director)
More from Chemomab Therapeutics Ltd.
Board/Management Information
2026
Jun 2
Report Publication Announcement
2026
May 14
Regulatory Filings
2026
Mar 19
Regulatory Filings
2025
Nov 21
Capital/Financing Update
2025
Aug 22
Interim / Quarterly Report
2025
Aug 14
Major Shareholding Notification
2025
Aug 11
Capital/Financing Update
2025
Jul 25
Capital/Financing Update
2025
Jul 25
Declaration of Voting Results & Voting Rights Announcements
2025
Jul 1